DRREDDY / NSE / Biotechnology & Drugs
Dr Reddy's Laboratories
1Y Price Trend
Key Information
Recommendations
RatingHold
Target High1,377.95
Target Low1,149
Target Mean2.76
Target Median20.39
Risk Metrics
Overall RiskBalanced risk
Board Risk26.54
Key Analysis
Overall score, performance score, return rating, defensive, aggressive, and balanced views.
Download appProjection Analytics
Best-case, base-case, worst-case, and dynamic AI projection views.
Download appLatest stock news
Dr. Reddy's Laboratories rallies Thursday, outperforms market MarketWatch
Q&A: Dr. Reddy's CEO on Generic Semaglutide and the GLP-1 Market Ahead Pharmaceutical Commerce
Dr. Reddy’s (NYSE: RDY) schedules June 2026 investor conferences in Mumbai and Hyderabad Stock Titan
Dr. Reddy's Laboratories falls Wednesday, underperforms competitors MarketWatch
Dr. Reddy's management to meet investors on June 9-10 scanx.trade
Dr. Reddy’s (NYSE: RDY) says DOJ and SEC close FCPA probes without enforcement Stock Titan
Dr. Reddy's Laboratories slides Tuesday, underperforms market MarketWatch
Dr Reddys Laboratories Ltd slips for fifth straight session Business Standard
© SharekeyX | Rusaka Technologies 2024-2026

